Compound Detail
CHEMBL3950712
DA-6886 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL3950712 |
| Name | DA-6886 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | AULLTYAISZREAX-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
1
Known Names
1
Indications
Molecular Properties
406.9
MW (Da)
2.05
ALogP
7
HBA
2
HBD
98.3
PSA (Ų)
0.65
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Irritable Bowel Syndrome
Activity Summary
IC50 1 meas. best 10.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | IC50 | 10.17 | 10.17 | 0.1 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | IC50 | = | 0.067 | nM | 10.17 | Binding Assay: The binding affinity of the compounds for a human 5-HT4 receptor ... | - |
Data from ChEMBL 36 via Core Engine